Correlation Between Tissue Regenix and Ashtead Technology

Can any of the company-specific risk be diversified away by investing in both Tissue Regenix and Ashtead Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tissue Regenix and Ashtead Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tissue Regenix Group and Ashtead Technology Holdings, you can compare the effects of market volatilities on Tissue Regenix and Ashtead Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tissue Regenix with a short position of Ashtead Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tissue Regenix and Ashtead Technology.

Diversification Opportunities for Tissue Regenix and Ashtead Technology

-0.71

Correlation Coefficient

Tissue Regenix  Ashtead Technology

Pay attention - limited upside

The 3 months correlation between Tissue and Ashtead is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Tissue Regenix Group and Ashtead Technology Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ashtead Technology and Tissue Regenix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tissue Regenix Group are associated (or correlated) with Ashtead Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ashtead Technology has no effect on the direction of Tissue Regenix i.e., Tissue Regenix and Ashtead Technology go up and down completely randomly.

Pair Corralation between Tissue Regenix and Ashtead Technology

Assuming the 90 days trading horizon Tissue Regenix is expected to generate 3.02 times less return on investment than Ashtead Technology. But when comparing it to its historical volatility, Tissue Regenix Group is 1.65 times less risky than Ashtead Technology. It trades about 0.02 of its potential returns per unit of risk. Ashtead Technology Holdings is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  45,936  in Ashtead Technology Holdings on October 5, 2024 and sell it today you would earn a total of  12,064  from holding Ashtead Technology Holdings or generate 26.26% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	99.68%
Values	Daily Returns

Tissue Regenix Group  vs.  Ashtead Technology Holdings

Tissue Regenix Group

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Tissue Regenix Group are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Tissue Regenix may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Ashtead Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Ashtead Technology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Ashtead Technology is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Tissue Regenix and Ashtead Technology

The main advantage of trading using opposite Tissue Regenix and Ashtead Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tissue Regenix position performs unexpectedly, Ashtead Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ashtead Technology will offset losses from the drop in Ashtead Technology's long position.

The idea behind Tissue Regenix Group and Ashtead Technology Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.